New Insights of Emerging SARS-CoV-2: Epidemiology, Etiology, Clinical Features, Clinical Treatment, and Prevention
Since the first reports that the novel coronavirus was showing human-to-human transmission characteristics and asymptomatic cases, the number of patients with associated pneumonia has continued to rise and the epidemic has grown. It now threatens the health and lives of people across the world. The...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2020-05-01
|
| Series: | Frontiers in Cell and Developmental Biology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/article/10.3389/fcell.2020.00410/full |
| _version_ | 1811208223687966720 |
|---|---|
| author | Gangqiang Guo Lele Ye Kan Pan Yu Chen Dong Xing Kejing Yan Zhiyuan Chen Ning Ding Wenshu Li Hong Huang Lifang Zhang Xiaokun Li Xiaokun Li Xiangyang Xue Xiangyang Xue |
| author_facet | Gangqiang Guo Lele Ye Kan Pan Yu Chen Dong Xing Kejing Yan Zhiyuan Chen Ning Ding Wenshu Li Hong Huang Lifang Zhang Xiaokun Li Xiaokun Li Xiangyang Xue Xiangyang Xue |
| author_sort | Gangqiang Guo |
| collection | DOAJ |
| description | Since the first reports that the novel coronavirus was showing human-to-human transmission characteristics and asymptomatic cases, the number of patients with associated pneumonia has continued to rise and the epidemic has grown. It now threatens the health and lives of people across the world. The governments of many countries have attached great importance to the prevention of SARS-CoV-2, via research into the etiology and epidemiology of this newly emerged disease. Clinical signs, treatment, and prevention characteristics of the novel coronavirus pneumonia have been receiving attention worldwide, especially from medical personnel. However, owing to the different experimental methods, sample sizes, sample sources, and research perspectives of various studies, results have been inconsistent, or relate to an isolated aspect of the virus or the disease it causes. Currently, systematic summary data on the novel coronavirus are limited. This review combines experimental and clinical evidence into a systematic analysis and summary of the current progress of research into SARS-CoV-2, from multiple perspectives, with the aim of gaining a better overall understanding of the disease. Our report provides important information for current clinicians, for the prevention and treatment of COVID-19 pneumonia. |
| first_indexed | 2024-04-12T04:17:34Z |
| format | Article |
| id | doaj.art-3ff467fa02904d1485b1a4cec7d7e868 |
| institution | Directory Open Access Journal |
| issn | 2296-634X |
| language | English |
| last_indexed | 2024-04-12T04:17:34Z |
| publishDate | 2020-05-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Cell and Developmental Biology |
| spelling | doaj.art-3ff467fa02904d1485b1a4cec7d7e8682022-12-22T03:48:20ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2020-05-01810.3389/fcell.2020.00410547151New Insights of Emerging SARS-CoV-2: Epidemiology, Etiology, Clinical Features, Clinical Treatment, and PreventionGangqiang Guo0Lele Ye1Kan Pan2Yu Chen3Dong Xing4Kejing Yan5Zhiyuan Chen6Ning Ding7Wenshu Li8Hong Huang9Lifang Zhang10Xiaokun Li11Xiaokun Li12Xiangyang Xue13Xiangyang Xue14Department of Microbiology and Immunology, School of Basic Medical Sciences, Institute of Molecular Virology and Immunology, Institute of Tropical Medicine, Wenzhou Medical University, Wenzhou, ChinaDepartment of Gynecologic Oncology, Wenzhou Central Hospital, Wenzhou, ChinaFirst Clinical College, Wenzhou Medical University, Wenzhou, ChinaSecond Clinical College, Wenzhou Medical University, Wenzhou, ChinaDepartment of Microbiology and Immunology, School of Basic Medical Sciences, Institute of Molecular Virology and Immunology, Institute of Tropical Medicine, Wenzhou Medical University, Wenzhou, ChinaDepartment of Microbiology and Immunology, School of Basic Medical Sciences, Institute of Molecular Virology and Immunology, Institute of Tropical Medicine, Wenzhou Medical University, Wenzhou, ChinaDepartment of Microbiology and Immunology, School of Basic Medical Sciences, Institute of Molecular Virology and Immunology, Institute of Tropical Medicine, Wenzhou Medical University, Wenzhou, ChinaDepartment of Microbiology and Immunology, School of Basic Medical Sciences, Institute of Molecular Virology and Immunology, Institute of Tropical Medicine, Wenzhou Medical University, Wenzhou, ChinaDepartment of Microbiology and Immunology, School of Basic Medical Sciences, Institute of Molecular Virology and Immunology, Institute of Tropical Medicine, Wenzhou Medical University, Wenzhou, ChinaCenter for Health Assessment, Wenzhou Medical University, Wenzhou, ChinaDepartment of Microbiology and Immunology, School of Basic Medical Sciences, Institute of Molecular Virology and Immunology, Institute of Tropical Medicine, Wenzhou Medical University, Wenzhou, ChinaSchool of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, ChinaInstitute of Virology, Wenzhou Medical University, Wenzhou, ChinaDepartment of Microbiology and Immunology, School of Basic Medical Sciences, Institute of Molecular Virology and Immunology, Institute of Tropical Medicine, Wenzhou Medical University, Wenzhou, ChinaInstitute of Virology, Wenzhou Medical University, Wenzhou, ChinaSince the first reports that the novel coronavirus was showing human-to-human transmission characteristics and asymptomatic cases, the number of patients with associated pneumonia has continued to rise and the epidemic has grown. It now threatens the health and lives of people across the world. The governments of many countries have attached great importance to the prevention of SARS-CoV-2, via research into the etiology and epidemiology of this newly emerged disease. Clinical signs, treatment, and prevention characteristics of the novel coronavirus pneumonia have been receiving attention worldwide, especially from medical personnel. However, owing to the different experimental methods, sample sizes, sample sources, and research perspectives of various studies, results have been inconsistent, or relate to an isolated aspect of the virus or the disease it causes. Currently, systematic summary data on the novel coronavirus are limited. This review combines experimental and clinical evidence into a systematic analysis and summary of the current progress of research into SARS-CoV-2, from multiple perspectives, with the aim of gaining a better overall understanding of the disease. Our report provides important information for current clinicians, for the prevention and treatment of COVID-19 pneumonia.https://www.frontiersin.org/article/10.3389/fcell.2020.00410/fullSARS-CoV-2coronavirusepidemiologyetiologyclinical featuresclinical treatment and prevention |
| spellingShingle | Gangqiang Guo Lele Ye Kan Pan Yu Chen Dong Xing Kejing Yan Zhiyuan Chen Ning Ding Wenshu Li Hong Huang Lifang Zhang Xiaokun Li Xiaokun Li Xiangyang Xue Xiangyang Xue New Insights of Emerging SARS-CoV-2: Epidemiology, Etiology, Clinical Features, Clinical Treatment, and Prevention Frontiers in Cell and Developmental Biology SARS-CoV-2 coronavirus epidemiology etiology clinical features clinical treatment and prevention |
| title | New Insights of Emerging SARS-CoV-2: Epidemiology, Etiology, Clinical Features, Clinical Treatment, and Prevention |
| title_full | New Insights of Emerging SARS-CoV-2: Epidemiology, Etiology, Clinical Features, Clinical Treatment, and Prevention |
| title_fullStr | New Insights of Emerging SARS-CoV-2: Epidemiology, Etiology, Clinical Features, Clinical Treatment, and Prevention |
| title_full_unstemmed | New Insights of Emerging SARS-CoV-2: Epidemiology, Etiology, Clinical Features, Clinical Treatment, and Prevention |
| title_short | New Insights of Emerging SARS-CoV-2: Epidemiology, Etiology, Clinical Features, Clinical Treatment, and Prevention |
| title_sort | new insights of emerging sars cov 2 epidemiology etiology clinical features clinical treatment and prevention |
| topic | SARS-CoV-2 coronavirus epidemiology etiology clinical features clinical treatment and prevention |
| url | https://www.frontiersin.org/article/10.3389/fcell.2020.00410/full |
| work_keys_str_mv | AT gangqiangguo newinsightsofemergingsarscov2epidemiologyetiologyclinicalfeaturesclinicaltreatmentandprevention AT leleye newinsightsofemergingsarscov2epidemiologyetiologyclinicalfeaturesclinicaltreatmentandprevention AT kanpan newinsightsofemergingsarscov2epidemiologyetiologyclinicalfeaturesclinicaltreatmentandprevention AT yuchen newinsightsofemergingsarscov2epidemiologyetiologyclinicalfeaturesclinicaltreatmentandprevention AT dongxing newinsightsofemergingsarscov2epidemiologyetiologyclinicalfeaturesclinicaltreatmentandprevention AT kejingyan newinsightsofemergingsarscov2epidemiologyetiologyclinicalfeaturesclinicaltreatmentandprevention AT zhiyuanchen newinsightsofemergingsarscov2epidemiologyetiologyclinicalfeaturesclinicaltreatmentandprevention AT ningding newinsightsofemergingsarscov2epidemiologyetiologyclinicalfeaturesclinicaltreatmentandprevention AT wenshuli newinsightsofemergingsarscov2epidemiologyetiologyclinicalfeaturesclinicaltreatmentandprevention AT honghuang newinsightsofemergingsarscov2epidemiologyetiologyclinicalfeaturesclinicaltreatmentandprevention AT lifangzhang newinsightsofemergingsarscov2epidemiologyetiologyclinicalfeaturesclinicaltreatmentandprevention AT xiaokunli newinsightsofemergingsarscov2epidemiologyetiologyclinicalfeaturesclinicaltreatmentandprevention AT xiaokunli newinsightsofemergingsarscov2epidemiologyetiologyclinicalfeaturesclinicaltreatmentandprevention AT xiangyangxue newinsightsofemergingsarscov2epidemiologyetiologyclinicalfeaturesclinicaltreatmentandprevention AT xiangyangxue newinsightsofemergingsarscov2epidemiologyetiologyclinicalfeaturesclinicaltreatmentandprevention |